Bisphosphonates May Reduce Intraoperative Blood Loss in Surgery for Metastatic Spinal Disease: A Retrospective Cohort Study

References

• Luksanapruksa P, Buchowski JM, Zebala LP, et al. Perioperative complications of spinal metastases surgery. Clin Spine Surg. 2017;30(1):4–13. doi:10.1097/BSD.000000000000048427984252
   PubMed Web of Science ®Google Scholar
• Atkinson RA, Jones A, Ousey K, Stephenson J. Management and cost of surgical site infection in patients undergoing surgery for spinal metastasis. J Hosp Infect. 2017;95(2):148–153. doi:10.1016/j.jhin.2016.11.01628027789
   PubMed Web of Science ®Google Scholar
• Quraishi NA, Rajabian A, Spencer A, et al. Reoperation rates in the surgical treatment of spinal metastases. Spine J. 2015;15(3 Suppl):S37–S43. doi:10.1016/j.spinee.2015.01.00525615847
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–648. doi:10.1016/S0140-6736(05)66954-116112300
   PubMed Web of Science ®Google Scholar
• Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J. 2013;95-b(5):683–688. doi:10.1302/0301-620X.95B5.3127023632682
   PubMed Web of Science ®Google Scholar
• Kumar N, Zaw AS, Khine HE, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol. 2016;23(6):2079–2086. doi:10.1245/s10434-016-5092-826819232
   PubMed Web of Science ®Google Scholar
• Reitz M, Mende KC, Cramer C, et al. Surgical treatment of spinal metastases from renal cell carcinoma-effects of preoperative embolization on intraoperative blood loss. Neurosurg Rev. 2018;41(3):861–867. doi:10.1007/s10143-017-0935-829189958
   PubMed Web of Science ®Google Scholar
• Schmidt R, Rupp-Heim G, Dammann F, et al. Surgical therapy of vertebral metastases. Are there predictive parameters for intraoperative excessive blood loss despite preoperative embolization? Tumori. 2011;97(1):66–73. doi:10.1177/03008916110970011321528667
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Child JA, Gregory WM, et al. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol. 2011;12(8):743–752. doi:10.1016/S1470-2045(11)70157-721771568
   PubMed Web of Science ®Google Scholar
• Lacerna L, Hohneker J. Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors. Semin Oncol. 2003;30(5 Suppl 16):150–160. doi:10.1053/j.seminoncol.2003.08.01714613036
   PubMed Web of Science ®Google Scholar
• Dhillon S, Lyseng-Williamson KA. Zoledronic acid: a review of its use in the management of bone metastases of malignancy. Drugs. 2008;68(4):507–534. doi:10.2165/00003495-200868040-0001018318568
   PubMed Web of Science ®Google Scholar
• Wu J, Zheng W, Tan Y, et al. Zoledronic acid may reduce intraoperative bleeding in spinal tumors: a prospective cohort study. Biomed Res Int. 2015;2015:936307.25685817
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi:10.1016/0895-4356(94)90129-57722560
   PubMed Web of Science ®Google Scholar
• van Middendorp JJ, Goss B, Urquhart S, et al. Diagnosis and prognosis of traumatic spinal cord injury. Global Spine J. 2011;1(1):1–8. doi:10.1055/s-0031-129604924353930
   PubMedGoogle Scholar
• Yang XG, Feng JT, Wang F, et al. Development and validation of a prognostic nomogram for the overall survival of patients living with spinal metastases. J Neurooncol. 2019;145(1):167–176. doi:10.1007/s11060-019-03284-y31549282
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X18064739
   PubMed Web of Science ®Google Scholar
• Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343(25):1826–1832. doi:10.1056/NEJM20001221343250111117973
   PubMed Web of Science ®Google Scholar
• Chen C, Dai JL. Triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2018;17(1):130. doi:10.1186/s12944-018-0776-729843793
   PubMed Web of Science ®Google Scholar
• Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13(Suppl 1):S3–S5. doi:10.1007/s00586-004-0753-x15197630
   PubMed Web of Science ®Google Scholar
• Tamburrelli FC, Proietti L, Scaramuzzo L, et al. Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report. Eur Spine J. 2012;21(Suppl S1):S141–S145. doi:10.1007/s00586-012-2231-122434531
   PubMed Web of Science ®Google Scholar
• Berenson JR, Hillner BE, Kyle RA, et al. American society of clinical oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20(17):3719–3736. doi:10.1200/JCO.2002.06.03712202673
   PubMed Web of Science ®Google Scholar
• Berenson JR, Rosen LS, Howell A, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer. 2001;91(7):1191–1200. doi:10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-011283917
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500–1524. doi:10.1016/j.ijsu.2014.07.01425046751
   PubMed Web of Science ®Google Scholar
• Erviti J, Alonso A, Oliva B, et al. Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study. BMJ Open. 2013;3(1):e002091. doi:10.1136/bmjopen-2012-002091
   PubMed Web of Science ®Google Scholar
• Rodan GA, Reszka AA. Bisphosphonate mechanism of action. Curr Mol Med. 2002;2(6):571–577. doi:10.2174/156652402336210412243249
   PubMedGoogle Scholar